Andrea Whittemore-Goad

Andrea Whittemore-Goad is a prominent American chronic fatigue syndrome (CFS) patient. Her experiences with CFS motivated her parents, Annette and Harvey Whittemore, and her physician, Daniel Peterson to found a CFS research laboratory, the Whittemore Peterson Institute (WPI). Whittemore-Goad has been interviewed in the US media
CFS
Whittemore-Goad recalls living as a "regular school girl" until developing an illness resembling mononucleosis at the age of ten. Whittemore-Goad experienced side effects and was forced to stop taking the medication. The Whittemores contributed $5 million of their own money In 2009, WPI and collaborating scientists reported that a retrovirus, the xenotropic murine leukemia virus-related virus (XMRV), causes or is associated with chronic fatigue syndrome. The report generated intense interest and controversy after another scientific research group failed to replicate WPI's results.
Publicity
Following the Whittemore Peterson Institute's publication on XMRV and CFS, Andrea Whittemore-Goad has been depicted in The New York Times
Advocacy
Whittemore-Goad has participated in CFS research and treatment advocacy. In 2003, she gave a statement to the Nevada State legislature concerning an amendment to a healthcare bill proposed by her father, lobbyist Harvey Whittemore. The amendment was designed to approve state payments for the experimental drug Ampligen for Nevada chronic fatigue syndrome patients. According to the Whittemores' statements, although they could afford the several thousand dollars every few months charged by the Nevada doctor who administered the treatment, other patients were unable to pay. Harvey Whittemore read his daughter's statement into the record. With her mother, Whittemore-Goad has contributed to public relations efforts for the Whittemore Peterson Institute.<ref name=Help/>
Family
Whittemore-Goad married in 2009 and was interviewed with her husband in The Wall Street Journal.<ref name=WSJ/>

Main Menu

See Also

Main Menu